Determinants of acceptance and subsequent uptake of the HPV vaccine in a cohort in Eldoret, Kenya

Through a longitudinal study in Eldoret, Kenya, HPV vaccine acceptability was measured before the implementation of a vaccination program (n=287) and the actual vaccine uptake, as reported by mothers, once the program was finished (n=256). The data contains potential barriers reported at baseline, barriers encountered at follow-up as well as socio-demographic information of the participants.